Connection
David Schwartz to Drug Resistance, Bacterial
This is a "connection" page, showing publications David Schwartz has written about Drug Resistance, Bacterial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.246 |
|
|
|
-
Dickstein Y, Solter E, Schwartz D, Nutman A, Harevrich I, Wulffhart L, Carmeli Y, Schwaber MJ. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study. Clin Microbiol Infect. 2021 Oct; 27(10):1518.e1-1518.e3.
Score: 0.163
-
Moran Gilad J, Carmeli Y, Schwartz D, Navon-Venezia S. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae. Diagn Microbiol Infect Dis. 2011 Aug; 70(4):565-7.
Score: 0.082